The Impact of Multi-Touch Functional Digital Game on Intelligence and Vitality for the Community-dwelling Elderly
20 de setembro de 2022 atualizado por: Samsung Medical Center
This single-blinded, randomized, controlled trial includes 32 elderly.
The participants were randomized to intervention(Happy Table) and control(cognitive stimulation activity) groups.
Each group is divided in 16 participants.
In one session, participants in the Happy Table group completed 40 minutes of intervention using Happy Table serious game, whereas those in the Control group completed 40 minutes of cognitive stimulation game.
Visão geral do estudo
Status
Concluído
Condições
Intervenção / Tratamento
Descrição detalhada
At the first visit, the subjects are fully informed of the study if appropriate after determining whether they meet the selection criteria.
This single-blinded, randomized, controlled trial includes 32 elderly.
The participants were randomized to intervention(Happy Table) and control(cognitive stimulation activity) groups.
Each group is divided in 16 participants.
In one session, participants in the Happy Table group completed 40 minutes of intervention using Happy Table serious game, whereas those in the Control group completed 40 minutes of cognitive stimulation game.
Tipo de estudo
Intervencional
Inscrição (Real)
32
Estágio
- Não aplicável
Contactos e Locais
Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.
Locais de estudo
-
-
-
Seoul, Republica da Coréia, 06351
- Samsung Medical Center
-
-
Critérios de participação
Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.
Critérios de elegibilidade
Idades elegíveis para estudo
65 anos a 84 anos (Adulto mais velho)
Aceita Voluntários Saudáveis
Sim
Gêneros Elegíveis para o Estudo
Tudo
Descrição
Inclusion Criteria:
- community-dwelling senior citizens aged 65 to 84
- Those without a history of central nervous system(CNS) disease
Exclusion Criteria:
- When it is difficult to understand the task performance due to severe cognitive decline(Korean Simple Mental State Test, K-MMSE 10 points or less).
- When it is difficult to use this game device due to problems such as decreased vision or fracture of the upper limb
- In case of accompanying serious mental illness
Plano de estudo
Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Prevenção
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Functional digital game training group
These functional digital game programs have been developed to improve the intelligence and vitality in the community-dwelling elderly.
The program includes sub-categories such as attention, working memory, memory and executive functions with various levels of difficulty.
|
Functional digital game training group is divided in 16 participants.
In one session, participants in the functional digital game training group completed 40 minutes of intervention using various functional digital game such as working memory, memory, and attention.
(Total 10 session)
|
|
Experimental: Individual cognitive training
Individual cognitive training has been used to improve the intelligence and cognitive function in community-dwelling elderly.
The program includes sub-categories such as attention, working memory, memory and executive functions with various levels of difficulty.
|
Functional digital game training group is divided in 16 participants.
In one session, participants in the individual cognitive training group completed 40 minutes of intervention using various cognitive training such as working memory, memory, and attention.
(Total 10 session)
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change from baseline performance on Stroop test (Neuropsychological test) after the intervention (Day 13).
Prazo: Baseline, After the intervention (Day 13)
|
It measures a participant's processing speed, selective attention and inhibitory control.
The participant will be asked to read 'word' of the colored words or 'name of the color' of the colored words in separate trials.
The main scores produced in this test are completion time and errors.
The contrast score of the two trial's completion time means interference.
|
Baseline, After the intervention (Day 13)
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change from baseline performance on Fluency Test (Neuropsychological test) after the intervention (Day 13).
Prazo: Baseline, After the intervention (Day 13)
|
This is a generative naming test.
That measure how many words you can spontaneously speak within a limited time of words that fall into a specific category (e.g.
animals, store goods, vegetables) or words starting with a letter (e.g.
F • A • S or C·F·L).
|
Baseline, After the intervention (Day 13)
|
|
Change from baseline performance on Trail Making Test (Neuropsychological test) after the intervention (Day 13).
Prazo: Baseline, After the intervention (Day 13)
|
It consists of type A and type B trials.
The participant should connect the numbers (1~25) as quickly as possible in Type A trial, and connect the numbers (1~13) and alphabets (A~L) alternatively as quickly as possible in type B trial.
The main scores produced in this test are completion time and errors.
Higher score means worse performance.
|
Baseline, After the intervention (Day 13)
|
|
Change from baseline performance on Digit Span Test (Neuropsychological test) after the intervention (Day 13).
Prazo: Baseline, After the intervention (Day 13)
|
It measures auditory attention span and includes forward and backward trials.
The participant listens to a series of numbers and calls the sequence correctly.
The sequence increases in each trial.
The final score is the longest number of sequential digits that the participant can remember correctly.
The scores range from 3 to 8. The higher the score, the better the performance.
|
Baseline, After the intervention (Day 13)
|
|
Change from baseline performance on Auditory Verbal Learning test (Neuropsychological test) after the intervention (Day 13).
Prazo: Baseline, After the intervention (Day 13)
|
It measures participant's verbal memory.
The participant will hear 15 words and recall them immediately and after 20 minutes again.
The main scores produced in this test are the numbers of recalled words of the immediate and delayed trials.
Immediate memory score is the sum of 5 trial's correct response and score ranges between 0 and 60.
Delayed memory score is the correct response of the delayed trial and the score range is 0 to 15.
Higher score means better performance.
|
Baseline, After the intervention (Day 13)
|
|
Change from baseline activity on functional Near-Infrared Spectroscopy (fNIRS) during the intervention(Day 1 and 12)and after intervention completion(Day 12)
Prazo: Baseline, during the intervention(Day 1 and 12), Through intervention completion(Day 12)
|
It measures brain activity during cognitive tasks to see if cognitive training affects brain function.
|
Baseline, during the intervention(Day 1 and 12), Through intervention completion(Day 12)
|
|
Change from baseline activity on Contrasting Program/Go-No-Go test after the intervention (Day 13).
Prazo: Baseline, Day 13(After the intervention)
|
The Contrasting Program and go-no go test requires a subject to emit a simple motor response to one cue while inhibiting the response in the presence of another cue.
This test has been effective in demonstrating impulsivity (elevated commission error rate) in elderly with attention deficit.
|
Baseline, Day 13(After the intervention)
|
|
Change from baseline activity on Geriatric Depression Scale (GDS) after the intervention (Day 13).
Prazo: Baseline, After the intervention (Day 13)
|
GDS is a 15-item self-report assessment used to identify depression in the elderly.
A score of 0 to 5 is normal.
A score greater than 5 suggests depression
|
Baseline, After the intervention (Day 13)
|
|
Change from baseline activity on health-related quality of life instrument with 20 items (HINT-20) after the intervention (Day 13).
Prazo: Baseline, After the intervention (Day 13)
|
The total score of the HINT-20 is converted to a 0-100 scale, with higher scores indicating better health-related quality of life.
|
Baseline, After the intervention (Day 13)
|
|
Change from baseline activity on General Self-Efficacy Scale (GSE) after the intervention (Day 13).
Prazo: Baseline, After the intervention (Day 13)
|
General self-efficacy (GSE), individuals'belief in their ability to perform well in a variety of situations.
General self-efficacy (GSE) is the belief in one's competence to attempt difficult or novel tasks, and to cope with adversity arising from specific demanding situations.
|
Baseline, After the intervention (Day 13)
|
|
Change from baseline activity on International Physical Activity Questionnaire after the intervention (Day 13).
Prazo: Baseline, After the intervention (Day 13)
|
Physical Activity Questionnaire collects information on physical activity participation in three settings (or domains) as well as sedentary behaviour, comprising 16 questions.
|
Baseline, After the intervention (Day 13)
|
|
User Satisfaction Questionnaire after intervention.
Prazo: After the intervention (Day 13)
|
We evaluate the satisfaction questionnaire for each training.
|
After the intervention (Day 13)
|
|
Change from baseline activity on smart band activity through intervention completion(Day 12).
Prazo: Baseline, through intervention completion(Day 12)
|
Each participant was given an smart band(number of steps count) and instructed to wear it on the wrist during waking hours until completion of the training program.
This included both intervening training days (totaling 10).
|
Baseline, through intervention completion(Day 12)
|
Colaboradores e Investigadores
É aqui que você encontrará pessoas e organizações envolvidas com este estudo.
Patrocinador
Datas de registro do estudo
Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.
Datas Principais do Estudo
Início do estudo (Real)
16 de setembro de 2021
Conclusão Primária (Real)
21 de fevereiro de 2022
Conclusão do estudo (Real)
4 de agosto de 2022
Datas de inscrição no estudo
Enviado pela primeira vez
5 de abril de 2021
Enviado pela primeira vez que atendeu aos critérios de CQ
4 de maio de 2021
Primeira postagem (Real)
5 de maio de 2021
Atualizações de registro de estudo
Última Atualização Postada (Real)
22 de setembro de 2022
Última atualização enviada que atendeu aos critérios de controle de qualidade
20 de setembro de 2022
Última verificação
1 de abril de 2021
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Outros números de identificação do estudo
- 2021-03-011
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Não
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Não
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .